1. The Open Access Publisher BioMed Central, an information provider with a different approach CLIST 18-04-2005

2. What is BioMed Central? Independent online publishing house Peer-reviewed research Covers all areas of medicine and biology Immediate, barrier-free open access Reverse the traditional business model

3. BioMed Central The service provider Faculty of 1000 – www.facultyof1000.comwww.facultyof1000.com images.MD – www.images.mdwww.images.md Genome Biology – http://genomebiology.comhttp://genomebiology.com Arthritis Research – http://arthritis-research.comhttp://arthritis-research.com B C R – http:// breast-cancer-research.comhttp:// breast-cancer-research.com Critical Care Forum- http://ccforum.comhttp://ccforum.com C R – www.current-reports.comwww.current-reports.com C T O – www.treatment-options.comwww.treatment-options.com

4. Agenda Traditional publishing model BMC Open Access publishing model BMC Open Access journals Success of BMC journals Membership Subscription services

5. Current Publishing model Subscription or licence, payable to obtain access Authors hand over copyrights to the publisher

6. Publisher Free Use Manuscript Today’s (soon yesterday’s) print-derived model: Only those who can afford expensive subscriptions or licences have access Result: Author transfers copyright or exclusive publishing rights ©

7. What’s wrong with it? Severe disadvantages of restrictive access Political Argument – Pay taxes, have access Increasing cost of subscriptions Increasing number of journals (you can not have it all!) Transfer of copyright

8. To be useful, scientific results need to be used, read, cited, shared, applied, extended, built-upon So are they? So are they? So are they? So are they? So are they? So are they? So are they? So are they? So are they? So are they? So are they? So are they? So are they? For that, they must be accessible

9. what we need is: Unlimited dissemination for Optimal use

10. Only Open Access delivers that! Open Access publishing models therefore deserve the wholehearted support from the science community

11. What is Open Access? The article is universally and freely accessible via the Internet The authors retain copyright to their article Deposited immediately upon publication, in an internationally recognized open access repository (such as PubMed Central).

12. How is Open Access achieved at BioMed Central? Reversing the business model Article processing charge of £450-£835 per published article  Waivers are available  No colour charges or other ‘hidden’ charges Institutional Membership

13. Publisher Manuscript Tomorrow’s (today’s at BioMed Central) online-based model: Everyone has access All use is fair use Result: £450 Author pays small amount of money or rather, institution pays on author’s behalf OPEN @ CCESS

14. BioMed Central re-defines publishing Selling contentSelling service Acquiring the rights to content, facilitating peer review, making web-ready, hosting, and embedding in the literature and then selling the content Leaving the rights with the author, just facilitating peer review, making web-ready, hosting, and embedding in the literature, and making the content freely available

15. Benefits of publishing in open access journals? Free Access =Maximum Visibility Higher chances to be cited Immediate publication and included in PubMed Authors retain copyright Substantial save up to institutions and their libraries BMC promotes selected articles

17. Other facts about publishing with BMC Peer Review: all papers are peer reviewed in the ‘traditional’ way Secure Archiving: all articles are permanently archived in PubMed Central, INIST (others to be announced) Searchable and retrievable: all included in PubMed, Scirus, Google, CrossRef, HINARI (some journals are indexed in MEDLINE, Biosis, CAS, an increasing number tracked by ISI for citations )

18. Indexing PubMed all BMC journals Medline45 titles ISI18 titles BIOSIS 24 titles CASall BMC journals Citebaseall BMC journals EMBASE4 titles CABI49 titles https://www.biomedcentral.com/info/libraries/indexing

19. BioMed Central’s Journals Over 120 open access journals in total in all areas of biology and medicine Access to all peer-reviewed research content is free Highly Selective, general interest: Journal of Biology Edited by Martin Raff Free access to outstanding peer-reviewed research in biology Selective, high community interest: BMC Medicine and BMC Biology –Publishing peer-reviewed research articles of high quality and broad interest –Highlighting the best research from the BMC Series Sound science, range of interest: –60 BMC series journals –60 externally run specialist journals, varying interest and selectivity

21. Success of BMC journals General: Increase of submissions 3 fold increase in number of submissions in the past year Example of experience: Most successful journal so far: BMC Bioinformatics Publishes ~10 articles per month Rated in top 2 journals in this field by peers 1 article published in 2002 has 51 citations  Aiming for this achievement in our other journals

22. Starting a journal with BMC How? Provide a scope statement Assemble an editorial board – must demonstrate scientific credibility Select a journal title Provide lists of potential authors BioMed Central provides a publishing platform, a website and technical expertise for the journals

23. Examples of new journals published by BioMed Central

24. BioMed Central’s Membership Service offered to institutions to ensure dissemination of research Processing charges automatically waived 15% discount on BioMed Central’s subscription products Customised page on the BMC site Annual fee will depend on the total number of graduates, post-graduates, researchers and academics at the institution

25. There are now almost 400 BioMed Central members, including: –CAUL & CEIRC (Australia) bought 16 licenses –Harvard University –World Health Organization –CNRS, France –Whole State of Ohio –Walter & Eliza Hall Institute of Medical Research –Max Planck Society –University of California (all campuses) –ALL UK Universities –NHS England (Public Hospitals) There are now over 500 BioMed Central members, including: –Karolinska Institute –Harvard University –CNRS –NIH (National Institute of Health) –OhioLink –Max Planck Society –University of California (all 9 campuses) –ALL UK Universities –NHS England (Public Hospitals)

27. How can you support open access? Add our URL to your intranet or web pages Catalogue our journals Advocate our model of publishing to other researchers/scientists

28. Medical Collection Images.MD –Online encyclopaedia of medical images Critical Care –Research and review journal Current Reports –21 titles; review journals Current Treatment Options –4 titles; review journals natashar: "I think it is now clear that BioMed Central is destined to become one of the dominant online scientific publishers. I feel very strongly that this form of publication represents an important advance in scientific communication. It makes all publications free to anyone that has access to the internet - opening up access to the third world. In addition, it is superior to print journals because there are no space limits, or limits on number or color figures, along with the ability to include detailed lists of data, etc. I have published six articles in BioMed Central journals in the last two years. I have been very impressed with the high standards and quality of the reviews that I have received. I have had nothing but positive experiences of BioMed Central." David Levitt, MD, PhD Professor of Physiology University of Minnesota natashar: "I think it is now clear that BioMed Central is destined to become one of the dominant online scientific publishers. I feel very strongly that this form of publication represents an important advance in scientific communication. It makes all publications free to anyone that has access to the internet - opening up access to the third world. In addition, it is superior to print journals because there are no space limits, or limits on number or color figures, along with the ability to include detailed lists of data, etc. I have published six articles in BioMed Central journals in the last two years. I have been very impressed with the high standards and quality of the reviews that I have received. I have had nothing but positive experiences of BioMed Central." David Levitt, MD, PhD Professor of Physiology University of Minnesota

29. Biology Collection Faculty of 1000 –Scientific literature awareness tool Genome Biology –Research and review journal Breast Cancer Research –Research and review journal Arthritis Research & Therapy –Research and review journal natashar: "I think it is now clear that BioMed Central is destined to become one of the dominant online scientific publishers. I feel very strongly that this form of publication represents an important advance in scientific communication. It makes all publications free to anyone that has access to the internet - opening up access to the third world. In addition, it is superior to print journals because there are no space limits, or limits on number or color figures, along with the ability to include detailed lists of data, etc. I have published six articles in BioMed Central journals in the last two years. I have been very impressed with the high standards and quality of the reviews that I have received. I have had nothing but positive experiences of BioMed Central." David Levitt, MD, PhD Professor of Physiology University of Minnesota natashar: "I think it is now clear that BioMed Central is destined to become one of the dominant online scientific publishers. I feel very strongly that this form of publication represents an important advance in scientific communication. It makes all publications free to anyone that has access to the internet - opening up access to the third world. In addition, it is superior to print journals because there are no space limits, or limits on number or color figures, along with the ability to include detailed lists of data, etc. I have published six articles in BioMed Central journals in the last two years. I have been very impressed with the high standards and quality of the reviews that I have received. I have had nothing but positive experiences of BioMed Central." David Levitt, MD, PhD Professor of Physiology University of Minnesota

30. Pharmaceutical Collection Current Opinion in Drug Discovery & Development Current Opinion in Investigational Drugs Current Opinion in Molecular Therapeutics IDrugs natashar: "I think it is now clear that BioMed Central is destined to become one of the dominant online scientific publishers. I feel very strongly that this form of publication represents an important advance in scientific communication. It makes all publications free to anyone that has access to the internet - opening up access to the third world. In addition, it is superior to print journals because there are no space limits, or limits on number or color figures, along with the ability to include detailed lists of data, etc. I have published six articles in BioMed Central journals in the last two years. I have been very impressed with the high standards and quality of the reviews that I have received. I have had nothing but positive experiences of BioMed Central." David Levitt, MD, PhD Professor of Physiology University of Minnesota natashar: "I think it is now clear that BioMed Central is destined to become one of the dominant online scientific publishers. I feel very strongly that this form of publication represents an important advance in scientific communication. It makes all publications free to anyone that has access to the internet - opening up access to the third world. In addition, it is superior to print journals because there are no space limits, or limits on number or color figures, along with the ability to include detailed lists of data, etc. I have published six articles in BioMed Central journals in the last two years. I have been very impressed with the high standards and quality of the reviews that I have received. I have had nothing but positive experiences of BioMed Central." David Levitt, MD, PhD Professor of Physiology University of Minnesota

31. Thank you! Marianne Josserand marianne@biomedcentral.com +44 207 631 9990